Stay updated on Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.

Latest updates to the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record for the completed Phase 1 INBRX-101 study is displayed, with details about the study design, participant eligibility, locations, and outcome measures. The previous access-denied error is no longer shown.SummaryDifference49%

- Check8 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0. The study page continues to show a 403 Forbidden error rather than study details.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now shows a 403 Forbidden error, making the study record content inaccessible. Access restrictions prevent viewing the page content.SummaryDifference18%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new version of the page content. This reflects a recent update to the study details page rather than changes to the study data itself.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.